These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9409653)

  • 21. Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein.
    Engvig JP; Olsen KE; Gislefoss RE; Sletten K; Wahlström O; Westermark P
    Scand J Immunol; 1998 Jul; 48(1):92-8. PubMed ID: 9714416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fragments of the constant region of immunoglobulin light chains are constituents of AL-amyloid proteins.
    Olsen KE; Sletten K; Westermark P
    Biochem Biophys Res Commun; 1998 Oct; 251(2):642-7. PubMed ID: 9792827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonamyloidotic monoclonal immunoglobulin deposition disease. Light-chain, heavy-chain, and light- and heavy-chain deposition diseases.
    Buxbaum J; Gallo G
    Hematol Oncol Clin North Am; 1999 Dec; 13(6):1235-48. PubMed ID: 10626147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. pH-dependent fibrillogenesis of a VkappaIII Bence Jones protein.
    Rostagno A; Vidal R; Kaplan B; Chuba J; Kumar A; Elliott JI; Frangione B; Gallo G; Ghiso J
    Br J Haematol; 1999 Dec; 107(4):835-43. PubMed ID: 10606892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary structure of a monoclonal kappa chain in myeloma with light chain deposition disease.
    Khamlichi AA; Aucouturier P; Silvain C; Bauwens M; Touchard G; Preud'homme JL; Nau F; Cogné M
    Clin Exp Immunol; 1992 Jan; 87(1):122-6. PubMed ID: 1733627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disappearance of immunoglobulins from persistent renal amyloid deposits following stem cell transplantation for heavy-and light-chain amyloidosis.
    Safadi S; Saad A; Quint PS; Sethi S; Leung N; Kurtin P; Nasr SH
    Nephrol Dial Transplant; 2015 Jul; 30(7):1151-5. PubMed ID: 25796445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myeloma.
    Samanez C; Domingo A; Cibeira MT; Miquel R; Soler M; Bladé J
    Eur J Haematol; 2006 Jan; 76(1):83-5. PubMed ID: 16343276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
    Harris DL; King E; Ramsland PA; Edmundson AB
    J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localized laryngeal amyloidosis: partial characterization of an amyloid fibril protein AL.
    Westermark P; Sletten K; Pitkänen P; Natvig JB; Lindholm CE
    Mol Immunol; 1982 Mar; 19(3):447-50. PubMed ID: 6808355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonamyloidotic monoclonal immunoglobulin deposits lack amyloid P component.
    Gallo G; Picken M; Frangione B; Buxbaum J
    Mod Pathol; 1988 Nov; 1(6):453-6. PubMed ID: 3146753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Both the environment and somatic mutations govern the aggregation pathway of pathogenic immunoglobulin light chain.
    Davis DP; Gallo G; Vogen SM; Dul JL; Sciarretta KL; Kumar A; Raffen R; Stevens FJ; Argon Y
    J Mol Biol; 2001 Nov; 313(5):1021-34. PubMed ID: 11700059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pulmonary amyloidosis and non-amyloid immunoglobulin deposits].
    Cordier JF
    Rev Mal Respir; 2008 Jun; 25(6):743-65. PubMed ID: 18772831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical characterization of amyloid derived from the variable region of the kappa light chain subgroup III.
    Picken MM; Gallo GR; Pruzanski W; Frangione B
    Arthritis Rheum; 1990 Jun; 33(6):880-4. PubMed ID: 2114114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.
    Clos AL; Lasagna-Reeves CA; Castillo-Carranza DL; Sengupta U; Jackson GR; Kelly B; Beachkofsky TM; Kayed R
    Br J Dermatol; 2011 Dec; 165(6):1349-54. PubMed ID: 21729025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction in mice of human light-chain-associated amyloidosis.
    Solomon A; Weiss DT; Pepys MB
    Am J Pathol; 1992 Mar; 140(3):629-37. PubMed ID: 1546744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical subtyping of amyloid in formalin-fixed tissue samples confirms and supplements immunohistologic data.
    Kaplan B; Martin BM; Livneh A; Pras M; Gallo GR
    Am J Clin Pathol; 2004 Jun; 121(6):794-800. PubMed ID: 15198349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tertiary structure of an amyloid immunoglobulin light chain protein: a proposed model for amyloid fibril formation.
    Schormann N; Murrell JR; Liepnieks JJ; Benson MD
    Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9490-4. PubMed ID: 7568160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Backbone and side-chain (1)H, (13)C and (15)N resonance assignments of LEN, a human immunoglobulin kappaIV light-chain variable domain.
    Mukherjee S; Pondaven SP; Höfer N; Jaroniec CP
    Biomol NMR Assign; 2009 Dec; 3(2):255-9. PubMed ID: 19768664
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin kappa light chain and its amyloidogenic mutants: a molecular dynamics study.
    Nowak M
    Proteins; 2004 Apr; 55(1):11-21. PubMed ID: 14997536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel type of familial transthyretin amyloidosis, ATTR Asn124Ser, with co-localization of kappa light chains.
    Bergström J; Patrosso MC; Colussi G; Salvadore M; Penco S; Lando G; Marocchi A; Ueda A; Nakamura M; Ando Y
    Amyloid; 2007 Jun; 14(2):141-5. PubMed ID: 17577687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.